19 research outputs found
Recommended from our members
Phase 3 (P3) study of quizartinib (Q) or placebo (P) with induction (IND) and consolidation chemotherapy (CON) and as maintenance (MN) in patients (pts) with newly diagnosed (NDx) FLT3 -ITD–positive acute myeloid leukemia (AML): the QuANTUM-First study
Recommended from our members